Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 49 Carcinoma, Renal Cell 30 Neoplasm Metastasis 18 Neoplasms 15 Kidney Neoplasms 14 Neuroendocrine Tumors 11 Carcinoma, Neuroendocrine 9 Prostatic Neoplasms 7 Melanoma 7 Triple Negative Breast Neoplasms 6 Thyroid Neoplasms 6 Sarcoma 6 Meningioma 6 Lymphoma 6 Glioma 6 Endometrial Neoplasms 6 Tuberous Sclerosis 5 Stomach Neoplasms 5 Recurrence 5 Lymphoma, Mantle-Cell 5 Head and Neck Neoplasms 5 Colorectal Neoplasms 5 Carcinoma, Hepatocellular 5 Carcinoma 5 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 4 Liver Neoplasms 4 Carcinoma, Islet Cell 4 Astrocytoma 4

Interventions

Filgrastim 4 Ifosfamide 3 Carboplatin 3 Peripheral Blood Stem Cell Transplantation 2 Immune Checkpoint Inhibitors 2 Etoposide 2 spartalizumab 1 regorafenib 1 perifosine 1 pegfilgrastim 1 pazopanib 1 ivosidenib 1 etoposide phosphate 1 enasidenib 1 drozitumab 1 angiotensin I (1-7) 1 alanosine 1 abemaciclib 1 Vincristine 1 Trabectedin 1 Topotecan 1 Thiotepa 1 Sunitinib 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Image-Guided 1 Radiotherapy, Conformal 1 Radiotherapy 1 Radiosurgery 1 Proton Therapy 1 Pharmacogenomic Testing 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Chondrosarcoma × Everolimus × Clear all

NCT02008019 2017-08-07

CHONRAD

Centre Leon Berard

Phase 2 Suspended

Chondrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡